Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001179110-19-009746
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-21 16:17:44
Reporting Period:
2019-08-19
Accepted Time:
2019-08-21 16:17:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1597264 Blueprint Medicines Corp BPMC Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1638474 W. Jeffrey Albers C/o Blueprint Medicines Corporation
45 Sidney Street
Cambridge MA 02139
Ceo And President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-08-19 20,000 $1.87 48,961 No 4 M Direct
Common Stock Disposition 2019-08-19 100 $85.56 48,861 No 4 S Direct
Common Stock Disposition 2019-08-19 800 $84.42 48,061 No 4 S Direct
Common Stock Disposition 2019-08-19 300 $82.85 47,761 No 4 S Direct
Common Stock Disposition 2019-08-19 6,634 $82.04 41,127 No 4 S Direct
Common Stock Disposition 2019-08-19 12,166 $81.33 28,961 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2019-08-19 20,000 $0.00 20,000 $1.87
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
18,080 2024-07-30 No 4 M Direct
Footnotes
  1. Effected pursuant to a trading plan adopted on December 11, 2018 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.365 to $84.455 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (5) to this Form 4.
  3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $ $82.79 to $82.93 per share.
  4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $ $81.71 to $82.66 per share.
  5. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $ $80.71 to $81.695 per share.
  6. This option was granted on July 30, 2014. This option vested as follows: (i) 42,845 shares vested in four installments at a rate of 6,974 shares on September 21, 2016, and 11,957 shares on each of October 21, 2016 and November 21, 2016, and 11,957 on December 21, 2016; (ii) 90,010 shares vested in eight installments at a rate of 6,311 shares on May 21, 2017 and 11,957 shares on each of June 21, 2017, July 21, 2017, August 21, 2017, September 21, 2017, October 21, 2017, November 21, 2017 and December 21, 2017; and (iii) 30,225 shares vested in three installments at a rate of 6,311 shares on May 21, 2018, 11,957 shares on June 21, 2018 and 11,957 shares on July 21, 2018.